| Year |
Citation |
Score |
| 2024 |
Coley N, Zetterberg H, Cantet C, Guyonnet S, Ashton NJ, Vellas B, Blennow K, Andrieu S. Plasma p-tau181 as an outcome and predictor of multidomain intervention effects: a secondary analysis of a randomised, controlled, dementia prevention trial. The Lancet. Healthy Longevity. 5: e120-e130. PMID 38310892 DOI: 10.1016/S2666-7568(23)00255-6 |
0.611 |
|
| 2022 |
Andre L, Giulioli C, Piau A, Bongard V, Richard E, Moll van Charante EP, Coley N, Andrieu S. Telephone and Smartphone-Based Interventions for Cognitive and Cardio-Metabolic Health in Middle-Aged and Older Adults: A Systematic Review. Clinical Interventions in Aging. 17: 1599-1624. PMID 36393902 DOI: 10.2147/CIA.S352137 |
0.58 |
|
| 2022 |
Coley N, Giulioli C, Aisen PS, Vellas B, Andrieu S. Randomised controlled trials for the prevention of cognitive decline or dementia: A systematic review. Ageing Research Reviews. 82: 101777. PMID 36336171 DOI: 10.1016/j.arr.2022.101777 |
0.61 |
|
| 2022 |
Belleville S, Cloutier S, Mellah S, Vellas B, Andrieu S, Coley N, Ngandu T. Response to "Upping the dose of dementia risk reduction". Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35575626 DOI: 10.1002/alz.12693 |
0.468 |
|
| 2022 |
Belleville S, Cloutier S, Mellah S, Willis S, Vellas B, Andrieu S, Coley N, Ngandu T. Is more always better? Dose effect in a multidomain intervention in older adults at risk of dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35049127 DOI: 10.1002/alz.12544 |
0.541 |
|
| 2021 |
Coley N, Andre L, Hoevenaar-Blom M, Ngandu T, Beishuizen C, Barbera M, van Wanrooij L, Kivipelto M, Soininen H, van Gool WA, Brayne C, Moll van Charante E, Richard E, Andrieu S. Factors predicting engagement of older adults with a coach-supported eHealth intervention promoting lifestyle change, and associations between engagement and changes in cardiovascular and dementia risk: secondary analysis of an 18-month multinational randomized controlled trial. Journal of Medical Internet Research. PMID 35385395 DOI: 10.2196/32006 |
0.573 |
|
| 2021 |
Hafdi M, Eggink E, Hoevenaar-Blom MP, Witvliet MP, Andrieu S, Barnes L, Brayne C, Brooks R, Coley N, Georges J, van der Groep A, van Marwijk H, van der Meijden M, Song L, Song M, et al. Design and Development of a Mobile Health (mHealth) Platform for Dementia Prevention in the Prevention of Dementia by Mobile Phone Applications (PRODEMOS) Project. Frontiers in Neurology. 12: 733878. PMID 34975710 DOI: 10.3389/fneur.2021.733878 |
0.551 |
|
| 2021 |
Coley N, Coniasse-Brioude D, Igier V, Fournier T, Poulain JP, Andrieu S. Disparities in the participation and adherence of older adults in lifestyle-based multidomain dementia prevention and the motivational role of perceived disease risk and intervention benefits: an observational ancillary study to a randomised controlled trial. Alzheimer's Research & Therapy. 13: 157. PMID 34560903 DOI: 10.1186/s13195-021-00904-6 |
0.6 |
|
| 2021 |
Mura T, Coley N, Amieva H, Berr C, Gabelle A, Ousset PJ, Vellas B, Andrieu S. Cognitive decline as an outcome and marker of progression toward dementia, in early preventive trials. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34482607 DOI: 10.1002/alz.12431 |
0.609 |
|
| 2021 |
Eggink E, Hafdi M, Hoevenaar-Blom MP, Song M, Andrieu S, Barnes LE, Birck C, Brooks RL, Coley N, Ford E, Georges J, van der Groep A, van Gool WA, Handels R, Hou H, et al. Prevention of dementia using mobile phone applications (PRODEMOS): protocol for an international randomised controlled trial. Bmj Open. 11: e049762. PMID 34108173 DOI: 10.1136/bmjopen-2021-049762 |
0.557 |
|
| 2020 |
Guerville F, De Souto Barreto P, Coley N, Andrieu S, Mangin JF, Chupin M, Payoux P, Ousset PJ, Rolland Y, Vellas B. Kidney Function and Cognitive Decline in Older Adults: Examining the Role of Neurodegeneration. Journal of the American Geriatrics Society. PMID 33217785 DOI: 10.1111/jgs.16954 |
0.539 |
|
| 2020 |
Coley N, Hoevenaar-Blom MP, van Dalen JW, Moll van Charante EP, Kivipelto M, Soininen H, Andrieu S, Richard E. Dementia risk scores as surrogate outcomes for lifestyle-based multidomain prevention trials-rationale, preliminary evidence and challenges. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32803862 DOI: 10.1002/Alz.12169 |
0.605 |
|
| 2020 |
Akenine U, Barbera M, Beishuizen CR, Fallah Pour M, Guillemont J, Rosenberg A, Coley N, Mangialasche F, Salo L, Savy S, Pols AJ, Andrieu S, Richard E, Soininen H, Moll van Charante E, et al. Attitudes of at-risk older adults about prevention of cardiovascular disease and dementia using eHealth: a qualitative study in a European context. Bmj Open. 10: e037050. PMID 32764085 DOI: 10.1136/bmjopen-2020-037050 |
0.55 |
|
| 2020 |
van Wanrooij LL, Hoevenaar-Blom MP, Coley N, Ngandu T, Meiller Y, Guillemont J, Rosenberg A, Beishuizen CRL, Moll van Charante EP, Soininen H, Brayne C, Andrieu S, Kivipelto M, Richard E. Pooling individual participant data from randomized controlled trials: Exploring potential loss of information. Plos One. 15: e0232970. PMID 32396543 DOI: 10.1371/journal.pone.0232970 |
0.462 |
|
| 2020 |
Hooper C, Coley N, De Souto Barreto P, Payoux P, Salabert AS, Andrieu S, Weiner M, Vellas B. Cortical β-Amyloid in Older Adults Is Associated with Multidomain Interventions with and without Omega 3 Polyunsaturated Fatty Acid Supplementation. The Journal of Prevention of Alzheimer's Disease. 7: 128-134. PMID 32236402 DOI: 10.14283/jpad.2020.4 |
0.342 |
|
| 2020 |
Rosenberg A, Coley N, Soulier A, Kulmala J, Soininen H, Andrieu S, Kivipelto M, Barbera M. Experiences of dementia and attitude towards prevention: a qualitative study among older adults participating in a prevention trial. Bmc Geriatrics. 20: 99. PMID 32164544 DOI: 10.1186/S12877-020-1493-4 |
0.619 |
|
| 2020 |
Costa N, Mounié M, Pagès A, Guyonnet S, Carrié I, Coley N, Cantet C, Rapp T, Derumeaux-Burel H, Andrieu S, Vellas B, Molinier L. PND44 EVALUATION OF THE EFFICIENCY OF FOUR PREVENTION STRATEGIES IN ALZHEIMER'S DISEASE: RESULTS FROM THE MULTIDOMAIN ALZHEIMER PREVENTIVE TRIAL (MAPT) STUDY Value in Health. 23: S267. DOI: 10.1016/J.Jval.2020.04.937 |
0.61 |
|
| 2019 |
Richard E, Moll van Charante EP, Hoevenaar-Blom MP, Coley N, Barbera M, van der Groep A, Meiller Y, Mangialasche F, Beishuizen CB, Jongstra S, van Middelaar T, Van Wanrooij LL, Ngandu T, Guillemont J, Andrieu S, et al. Healthy ageing through internet counselling in the elderly (HATICE): a multinational, randomised controlled trial. The Lancet. Digital Health. 1: e424-e434. PMID 33323224 DOI: 10.1016/S2589-7500(19)30153-0 |
0.541 |
|
| 2019 |
Coley N, Ngandu T, Lehtisalo J, Soininen H, Vellas B, Richard E, Kivipelto M, Andrieu S. Adherence to multidomain interventions for dementia prevention: Data from the FINGER and MAPT trials. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31047857 DOI: 10.1016/J.Jalz.2019.03.005 |
0.623 |
|
| 2019 |
Chhetri JK, de Souto Barreto P, Cantet C, Cesari M, Coley N, Andrieu S, Vellas B. Trajectory of the MAPT-PACC-Preclinical Alzheimer Cognitive Composite in the Placebo Group of a Randomized Control Trial: Results from the MAPT Study: Lessons for Further Trials. The Journal of Prevention of Alzheimer's Disease. 5: 31-35. PMID 29405230 DOI: 10.14283/jpad.2017.21 |
0.417 |
|
| 2018 |
Coley N, Rosenberg A, van Middelaar T, Soulier A, Barbera M, Guillemont J, Steensma J, Igier V, Eskelinen M, Soininen H, Moll van Charante E, Richard E, Kivipelto M, Andrieu S, et al. Older Adults' Reasons for Participating in an eHealth Prevention Trial: A Cross-Country, Mixed-Methods Comparison. Journal of the American Medical Directors Association. PMID 30541689 DOI: 10.1016/J.Jamda.2018.10.019 |
0.56 |
|
| 2018 |
Coley N, Raman R, Donohue MC, Aisen PS, Vellas B, Andrieu S. Defining the Optimal Target Population for Trials of Polyunsaturated Fatty Acid Supplementation Using the Erythrocyte Omega-3 Index: A Step Towards Personalized Prevention of Cognitive Decline? The Journal of Nutrition, Health & Aging. 22: 982-998. PMID 30272103 DOI: 10.1007/S12603-018-1052-2 |
0.571 |
|
| 2018 |
Andre L, Gallini A, Montastruc F, Coley N, Montastruc JL, Vellas B, Andrieu S, Gardette V. Anticholinergic exposure and cognitive decline in older adults: Effect of anticholinergic exposure definitions in a 3-year analysis of the Multidomain Alzheimer Preventive Trial (MAPT) study. British Journal of Clinical Pharmacology. PMID 30098049 DOI: 10.1111/Bcp.13734 |
0.733 |
|
| 2018 |
Chhetri JK, de Souto Barreto P, Cantet C, Pothier K, Cesari M, Andrieu S, Coley N, Vellas B. Effects of a 3-Year Multi-Domain Intervention with or without Omega-3 Supplementation on Cognitive Function in Older Subjects with Increased CAIDE Dementia Scores. Journal of Alzheimer's Disease : Jad. PMID 29865075 DOI: 10.3233/Jad-180209 |
0.604 |
|
| 2018 |
Barbera M, Mangialasche F, Jongstra S, Guillemont J, Ngandu T, Beishuizen C, Coley N, Brayne C, Andrieu S, Richard E, Soininen H, Kivipelto M. Designing an Internet-Based Multidomain Intervention for the Prevention of Cardiovascular Disease and Cognitive Impairment in Older Adults: The HATICE Trial. Journal of Alzheimer's Disease : Jad. 62: 649-663. PMID 29480185 DOI: 10.3233/Jad-170858 |
0.637 |
|
| 2018 |
Hooper C, De Souto Barreto P, Coley N, Cantet C, Cesari M, Andrieu S, Vellas B. Cognitive Changes with Omega-3 Polyunsaturated Fatty Acids in Non-Demented Older Adults with Low Omega-3 Index. The Journal of Nutrition, Health & Aging. 21: 988-993. PMID 29083439 DOI: 10.1007/S12603-017-0957-5 |
0.534 |
|
| 2017 |
Hooper C, De Souto Barreto P, Coley N, Caussé E, Payoux P, Salabert AS, Cesari M, Andrieu S, Bowman GL, Weiner M, Vellas B. Cross-Sectional Associations of Total Plasma Homocysteine with Cortical β-Amyloid Independently and as a Function of Omega 3 Polyunsaturated Fatty Acid Status in Older Adults at Risk of Dementia. The Journal of Nutrition, Health & Aging. 21: 1075-1080. PMID 29188863 DOI: 10.1007/S12603-017-0989-X |
0.573 |
|
| 2017 |
Hooper C, De Souto Barreto P, Coley N, Cesari M, Payoux P, Salabert AS, Andrieu S, Vellas B. Cross-sectional Associations of Fatigue with Cerebral β-Amyloid in Older Adults at Risk of Dementia. Frontiers in Medicine. 4: 173. PMID 29164115 DOI: 10.3389/Fmed.2017.00173 |
0.554 |
|
| 2017 |
Hoevenaar-Blom MP, Guillemont J, Ngandu T, Beishuizen CRL, Coley N, Moll van Charante EP, Andrieu S, Kivipelto M, Soininen H, Brayne C, Meiller Y, Richard E. Improving data sharing in research with context-free encoded missing data. Plos One. 12: e0182362. PMID 28898245 DOI: 10.1371/Journal.Pone.0182362 |
0.528 |
|
| 2017 |
Coley N, Andrieu S. Lessons from the Multidomain Alzheimer Preventive Trial - Authors' reply. The Lancet. Neurology. 16: 586. PMID 28721923 DOI: 10.1016/S1474-4422(17)30226-0 |
0.624 |
|
| 2017 |
Andrieu S, Guyonnet S, Coley N, Cantet C, Bonnefoy M, Bordes S, Bories L, Cufi MN, Dantoine T, Dartigues JF, Desclaux F, Gabelle A, Gasnier Y, Pesce A, Sudres K, et al. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial. The Lancet. Neurology. PMID 28359749 DOI: 10.1016/S1474-4422(17)30040-6 |
0.603 |
|
| 2017 |
Beishuizen CR, Coley N, Moll van Charante EP, van Gool WA, Richard E, Andrieu S. Determinants of Dropout and Nonadherence in a Dementia Prevention Randomized Controlled Trial: The Prevention of Dementia by Intensive Vascular Care Trial. Journal of the American Geriatrics Society. PMID 28263374 DOI: 10.1111/jgs.14834 |
0.581 |
|
| 2017 |
Gallini A, Coley N, Andrieu S, Lapeyre-Mestre M, Gardette V. Effect of dementia on receipt of influenza vaccine: a cohort study in French older adults using administrative data: 2007-2012. Fundamental & Clinical Pharmacology. PMID 28258589 DOI: 10.1111/Fcp.12281 |
0.706 |
|
| 2017 |
Coley N, Ngandu T, Cantet C, Lehtisalo J, Vellas B, Kivipelto M, Andrieu S. ADHERENCE TO MULTIDOMAIN INTERVENTIONS FOR THE PREVENTION OF ALZHEIMER’S DISEASE: DATA FROM THE MAPT AND FINGER TRIALS Alzheimer's & Dementia. 13: P895-P896. DOI: 10.1016/J.Jalz.2017.07.306 |
0.615 |
|
| 2017 |
Coley N, Guillemont J, van Middelaar T, Barbera M, Rosenberg A, Soininen H, Igier V, Richard E, Kivipelto M, Andrieu S. ACCEPT–HATICE: A MIXED METHODS STUDY OF FACILITATORS AND BARRIERS TO PARTICIPATION IN AN INTERNET-BASED MULTIDOMAIN TRIAL FOR THE PREVENTION OF CARDIOVASCULAR DISEASE AND COGNITIVE DECLINE IN OLDER EUROPEAN ADULTS Alzheimer's & Dementia. 13: P1201-P1202. DOI: 10.1016/j.jalz.2017.06.1798 |
0.352 |
|
| 2016 |
Coley N, Gallini A, Ousset PJ, Vellas B, Andrieu S. Evaluating the clinical relevance of a cognitive composite outcome measure: An analysis of 1414 participants from the 5-year GuidAge Alzheimer's prevention trial. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27423962 DOI: 10.1016/J.Jalz.2016.06.002 |
0.651 |
|
| 2016 |
Richard E, Jongstra S, Soininen H, Brayne C, Moll van Charante EP, Meiller Y, van der Groep B, Beishuizen CR, Mangialasche F, Barbera M, Ngandu T, Coley N, Guillemont J, Savy S, Dijkgraaf MG, et al. Healthy Ageing Through Internet Counselling in the Elderly: the HATICE randomised controlled trial for the prevention of cardiovascular disease and cognitive impairment. Bmj Open. 6: e010806. PMID 27288376 DOI: 10.1136/bmjopen-2015-010806 |
0.553 |
|
| 2016 |
Richard E, Mangialsche F, Andrieu S, Barbera M, Beishuizen C, Brayne C, Coley N, van Gool WA, Guillemont J, Jongstra S, Moll van Charante EP, Ngandu T, Soininen H, Kivipelto M. P4-392: Healthy Ageing Through Internet Counselling in the Elderly (HATICE): an Ongoing Randomised Controlled Trial Alzheimer's & Dementia. 12: P1187-P1188. DOI: 10.1016/J.Jalz.2016.07.137 |
0.544 |
|
| 2015 |
Andrieu S, Coley N, Rolland Y, Cantet C, Arnaud C, Guyonnet S, Nourhashemi F, Grand A, Vellas B. Assessing Alzheimer's disease patients' quality of life: Discrepancies between patient and caregiver perspectives. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26602086 DOI: 10.1016/J.Jalz.2015.09.003 |
0.558 |
|
| 2015 |
Coley N, Gallini A, Garès V, Gardette V, Andrieu S. A Longitudinal Study of Transitions Between Informal and Formal Care in Alzheimer Disease Using Multistate Models in the European ICTUS Cohort. Journal of the American Medical Directors Association. 16: 1104.e1-7. PMID 26593306 DOI: 10.1016/J.Jamda.2015.09.010 |
0.728 |
|
| 2015 |
Di Stefano F, Epelbaum S, Coley N, Cantet C, Ousset PJ, Hampel H, Bakardjian H, Lista S, Vellas B, Dubois B, Andrieu S. Prediction of Alzheimer's Disease Dementia: Data from the GuidAge Prevention Trial. Journal of Alzheimer's Disease : Jad. 48: 793-804. PMID 26402073 DOI: 10.3233/Jad-150013 |
0.652 |
|
| 2015 |
Andrieu S, Coley N, Lovestone S, Aisen PS, Vellas B. Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directions. The Lancet. Neurology. 14: 926-44. PMID 26213339 DOI: 10.1016/S1474-4422(15)00153-2 |
0.644 |
|
| 2015 |
Coley N, Vaurs C, Andrieu S. Nutrition and Cognition in Aging Adults. Clinics in Geriatric Medicine. 31: 453-64. PMID 26195103 DOI: 10.1016/J.Cger.2015.04.008 |
0.621 |
|
| 2015 |
Coley N, Gallini A, Andrieu S. Prevention studies in Alzheimer's disease: progress towards the development of new therapeutics. Cns Drugs. 29: 519-28. PMID 26188654 DOI: 10.1007/s40263-015-0256-9 |
0.601 |
|
| 2015 |
Di Stefano F, Epelbaum S, Coley N, Cantet C, Ousset PJ, Hampel H, Bakardjian H, Lista S, Vellas B, Dubois B, Andrieu S, Baglio F. Prediction of Alzheimer's Disease Dementia: Data from the GuidAge Prevention Trial Journal of Alzheimer's Disease. 48: 793-804. DOI: 10.3233/JAD-150013 |
0.62 |
|
| 2015 |
Coley N, Garès V, Vellas B, Burns A, Pasquier F, Frisoni G, Salmon E, Michel JP, Boada M, Dartigues JF, Olde-Rikkert MGM, Rigaud AS, Winblad B, Malick A, Frölich L, et al. A Longitudinal Study of Transitions Between Informal and Formal Care in Alzheimer Disease Using Multistate Models in the European ICTUS Cohort Journal of the American Medical Directors Association. 16: 1104.e1-1104.e7. DOI: 10.1016/j.jamda.2015.09.010 |
0.703 |
|
| 2015 |
Vellas B, Carrie I, Guyonnet S, Touchon J, Dantoine T, Dartigues J, Cufi MN, Bordes S, Gasnier Y, Robert P, Bories L, Rouaud O, Desclaux F, Sudres K, Bonnefoy M, ... ... Coley N, et al. DT-01-01: MAPT (multi-domain Alzheimer's prevention trial): Results at 36 months Alzheimer's & Dementia. 11: P331-P331. DOI: 10.1016/J.Jalz.2015.08.151 |
0.591 |
|
| 2014 |
Kahle-Wrobleski K, Coley N, Lepage B, Cantet C, Vellas B, Andrieu S. Understanding the complexities of functional ability in Alzheimer's disease: more than just basic and instrumental factors. Current Alzheimer Research. 11: 357-66. PMID 24635843 DOI: 10.2174/1567205011666140317101419 |
0.579 |
|
| 2014 |
Di Stefano F, Epelbaum S, Coley N, Cantet C, Bakardjian H, Lista S, Hampel H, Vellas B, Dubois B, Andrieu S. P3-245: FREE AND CUED SELECTIVE REMINDING TEST (FCSRT) PERFORMANCE IN THE PREDICTION OF ALZHEIMER'S DISEASE DEMENTIA: DATA FROM A LARGE PREVENTION TRIAL (GUIDAGE) Alzheimer's & Dementia. 10: P721-P721. DOI: 10.1016/j.jalz.2014.05.1336 |
0.563 |
|
| 2013 |
Ferry M, Coley N, Andrieu S, Bonhomme C, Caubère JP, Cesari M, Gautry J, Garcia Sanchez I, Hugonot L, Mansuy L, Pahor M, Pariente J, Ritz P, Salva A, Sijben J, et al. How to design nutritional intervention trials to slow cognitive decline in apparently healthy populations and apply for efficacy claims: a statement from the International Academy on Nutrition and Aging Task Force. The Journal of Nutrition, Health & Aging. 17: 619-23. PMID 23933873 DOI: 10.1007/S12603-013-0350-Y |
0.603 |
|
| 2013 |
Cedarbaum JM, Jaros M, Hernandez C, Coley N, Andrieu S, Grundman M, Vellas B. Rationale for use of the Clinical Dementia Rating Sum of Boxes as a primary outcome measure for Alzheimer's disease clinical trials. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: S45-55. PMID 22658286 DOI: 10.1016/J.Jalz.2011.11.002 |
0.637 |
|
| 2013 |
Mangialasche F, Kivipelto M, Andrieu S, Coley N, Ngandu T, Moll van Charante E, Brayne C, Meiller Y, Van de Groep B, Soininen H, van Willem Gool A, Richard E. P4-398: Use of new technology to improve dementia prevention: The Healthy Aging Through Internet Counseling in the Elderly (HATICE) project Alzheimer's & Dementia. 9: P881-P881. DOI: 10.1016/j.jalz.2013.08.231 |
0.474 |
|
| 2012 |
Vellas B, Coley N, Ousset PJ, Berrut G, Dartigues JF, Dubois B, Grandjean H, Pasquier F, Piette F, Robert P, Touchon J, Garnier P, Mathiex-Fortunet H, Andrieu S. Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial. The Lancet. Neurology. 11: 851-9. PMID 22959217 DOI: 10.1016/S1474-4422(12)70206-5 |
0.624 |
|
| 2012 |
Gardette V, Lapeyre-Mestre M, Coley N, Cantet C, Montastruc JL, Vellas B, Andrieu S. Antipsychotic use and mortality risk in community-dwelling Alzheimer's disease patients: evidence for a role of dementia severity. Current Alzheimer Research. 9: 1106-16. PMID 22950915 DOI: 10.2174/156720512803569037 |
0.722 |
|
| 2012 |
Richard E, Andrieu S, Solomon A, Mangialasche F, Ahtiluoto S, Moll van Charante EP, Coley N, Fratiglioni L, Neely AS, Vellas B, van Gool WA, Kivipelto M. Methodological challenges in designing dementia prevention trials - the European Dementia Prevention Initiative (EDPI). Journal of the Neurological Sciences. 322: 64-70. PMID 22818266 DOI: 10.1016/j.jns.2012.06.012 |
0.607 |
|
| 2012 |
Andrieu S, Coley N, Gardette V, Subra J, Oustric S, Fournier T, Poulain JP, Coniasse-Brioude D, Igier V, Vellas B, Grand A. Representations and practices of prevention in elderly populations: investigating acceptance to participate in and adhesion to an intervention study for the prevention of Alzheimer's disease (ACCEPT study)--the need for a multidisciplinary approach. The Journal of Nutrition, Health & Aging. 16: 352-4. PMID 22499457 DOI: 10.1007/S12603-012-0045-9 |
0.748 |
|
| 2012 |
Soto ME, Andrieu S, Villars H, Secher M, Gardette V, Coley N, Nourhashemi F, Vellas B. Improving care of older adults with dementia: description of 6299 hospitalizations over 11 years in a special acute care unit. Journal of the American Medical Directors Association. 13: 486.e1-6. PMID 22264688 DOI: 10.1016/J.Jamda.2011.12.058 |
0.699 |
|
| 2011 |
Gillette-Guyonnet S, Andrieu S, Nourhashemi F, Gardette V, Coley N, Cantet C, Gauthier S, Ousset PJ, Vellas B. Long-term progression of Alzheimer's disease in patients under antidementia drugs. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 579-92. PMID 22055975 DOI: 10.1016/J.Jalz.2011.02.009 |
0.769 |
|
| 2011 |
Coley N, Andrieu S, Jaros M, Weiner M, Cedarbaum J, Vellas B. Suitability of the Clinical Dementia Rating-Sum of Boxes as a single primary endpoint for Alzheimer's disease trials. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 602-610.e2. PMID 21745761 DOI: 10.1016/J.Jalz.2011.01.005 |
0.654 |
|
| 2011 |
Rapp T, Grand A, Cantet C, Andrieu S, Coley N, Portet F, Vellas B. Public financial support receipt and non-medical resource utilization in Alzheimer's disease results from the PLASA study. Social Science & Medicine (1982). 72: 1310-6. PMID 21463914 DOI: 10.1016/J.Socscimed.2011.02.039 |
0.487 |
|
| 2011 |
Coley N, Gardette V, Cantet C, Gillette-Guyonnet S, Nourhashemi F, Vellas B, Andrieu S. How should we deal with missing data in clinical trials involving Alzheimer's disease patients? Current Alzheimer Research. 8: 421-33. PMID 21244348 DOI: 10.2174/156720511795745339 |
0.768 |
|
| 2011 |
Hampel H, Wilcock G, Andrieu S, Aisen P, Blennow K, Broich K, Carrillo M, Fox NC, Frisoni GB, Isaac M, Lovestone S, Nordberg A, Prvulovic D, Sampaio C, Scheltens P, ... ... Coley N, et al. Biomarkers for Alzheimer's disease therapeutic trials. Progress in Neurobiology. 95: 579-93. PMID 21130138 DOI: 10.1016/J.Pneurobio.2010.11.005 |
0.603 |
|
| 2011 |
Coley N, Gardette V, Cantet C, Gillette-Guyonnet S, Nourhashemi F, Vellas B, Andrieu S. How Should We Deal with Missing Data in Clinical Trials Involving Alzheimer's Disease Patients? Current Alzheimer Research. 999: 1-12. DOI: 10.2174/1567211212443482050 |
0.743 |
|
| 2010 |
Nourhashemi F, Andrieu S, Gillette-Guyonnet S, Giraudeau B, Cantet C, Coley N, Vellas B. Effectiveness of a specific care plan in patients with Alzheimer's disease: cluster randomised trial (PLASA study). Bmj (Clinical Research Ed.). 340: c2466. PMID 20522656 DOI: 10.1136/Bmj.C2466 |
0.548 |
|
| 2010 |
Gardette V, Andrieu S, Lapeyre-Mestre M, Coley N, Cantet C, Ousset PJ, Grand A, Monstastruc JL, Vellas B. Predictive factors of discontinuation and switch of cholinesterase inhibitors in community-dwelling patients with Alzheimer's disease: a 2-year prospective, multicentre, cohort study. Cns Drugs. 24: 431-42. PMID 20369907 DOI: 10.2165/11318010-000000000-00000 |
0.706 |
|
| 2009 |
Coley N, Andrieu S, Delrieu J, Voisin T, Vellas B. Biomarkers in Alzheimer's disease: not yet surrogate endpoints. Annals of the New York Academy of Sciences. 1180: 119-24. PMID 19906266 DOI: 10.1111/J.1749-6632.2009.04947.X |
0.644 |
|
| 2009 |
Abellan van Kan G, Rolland Y, Nourhashémi F, Coley N, Andrieu S, Vellas B. Cardiovascular disease risk factors and progression of Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 27: 240-6. PMID 19246908 DOI: 10.1159/000203365 |
0.579 |
|
| 2009 |
Andrieu S, Coley N, Aisen P, Carrillo MC, DeKosky S, Durga J, Fillit H, Frisoni GB, Froelich L, Gauthier S, Jones R, Jönsson L, Khachaturian Z, Morris JC, Orgogozo JM, et al. Methodological issues in primary prevention trials for neurodegenerative dementia. Journal of Alzheimer's Disease : Jad. 16: 235-70. PMID 19221415 DOI: 10.3233/Jad-2009-0971 |
0.635 |
|
| 2008 |
Vellas B, Coley N, Andrieu S. Disease modifying trials in Alzheimer's disease: perspectives for the future. Journal of Alzheimer's Disease : Jad. 15: 289-301. PMID 18953115 |
0.597 |
|
| 2008 |
Coley N, Andrieu S, Gardette V, Gillette-Guyonnet S, Sanz C, Vellas B, Grand A. Dementia prevention: methodological explanations for inconsistent results. Epidemiologic Reviews. 30: 35-66. PMID 18779228 DOI: 10.1093/Epirev/Mxn010 |
0.77 |
|
| 2008 |
Andrieu S, Ousset PJ, Coley N, Ouzid M, Mathiex-Fortunet H, Vellas B. GuidAge study: a 5-year double blind, randomised trial of EGb 761 for the prevention of Alzheimer's disease in elderly subjects with memory complaints. i. rationale, design and baseline data. Current Alzheimer Research. 5: 406-15. PMID 18690838 |
0.556 |
|
| 2008 |
Coley N, Gardette V, Toulza O, Gillette-Guyonnet S, Cantet C, Nourhashemi F, Andrieu S, Grand A, Vellas B. Predictive factors of attrition in a cohort of Alzheimer disease patients. The REAL.FR study. Neuroepidemiology. 31: 69-79. PMID 18622142 DOI: 10.1159/000144087 |
0.736 |
|
| 2008 |
Vellas B, Andrieu S, Sampaio C, Coley N, Wilcock G. Endpoints for trials in Alzheimer's disease: a European task force consensus. The Lancet. Neurology. 7: 436-50. PMID 18420157 DOI: 10.1016/S1474-4422(08)70087-5 |
0.637 |
|
| 2008 |
Coley N, Andrieu S, Berrut G, Ousset P, Garnier P, Mathiex-Fortunet H, Vellas B. P4-015: One-leg balance and cognitive function: Data from the baseline assessment of the GuidAge study Alzheimer's & Dementia. 4: T671-T671. DOI: 10.1016/J.Jalz.2008.05.2079 |
0.528 |
|
| Show low-probability matches. |